Zobrazeno 1 - 10
of 1 521
pro vyhledávání: '"Cooperberg P"'
Active surveillance (AS) using repeated biopsies to monitor disease progression has been a popular alternative to immediate surgical intervention in cancer care. However, a biopsy procedure is invasive and sometimes leads to severe side effects of in
Externí odkaz:
http://arxiv.org/abs/2405.11720
Autor:
Ryan Sutherland, Cary P. Gross, Xiaomei Ma, Farah Jeong, Tyler M. Seibert, Matthew R. Cooperberg, William J. Catalona, Shellie D. Ellis, Stacy Loeb, Dena Schulman‐Green, Michael S. Leapman
Publikováno v:
BJUI Compass, Vol 5, Iss 6, Pp 593-601 (2024)
Abstract Introduction Although prostate magnetic resonance imaging (MRI) is commonly used in the diagnosis, staging and active surveillance of prostate cancer, little is known about patient perspectives on MRI. Methods We performed a qualitative stud
Externí odkaz:
https://doaj.org/article/a716092646f0417b8cff9026b974b943
Autor:
Ivan de Kouchkovsky, Hao Nguyen, Hsin-Yu Chen, Xiaoxi Liu, Hecong Qin, Bradley A. Stohr, Romelyn Delos Santos, Michael A. Ohliger, Zhen Jane Wang, Robert A. Bok, Jeremy W. Gordon, Peder E.Z. Larson, Mary Frost, Kimberly Okamoto, Daniel Gebrezgiabhier, Matthew Cooperberg, Daniel B. Vigneron, John Kurhanewicz, Rahul Aggarwal
Publikováno v:
Journal of Magnetic Resonance Open, Vol 21, Iss , Pp 100165- (2024)
Background: Although multiparametric (mp) 1H magnetic resonance imaging (MRI) is increasingly used to detect and localize prostate cancer (PC), its correlation with tumor grade is limited. Hyperpolarized (HP) carbon-13 (13C) MR is an emerging imaging
Externí odkaz:
https://doaj.org/article/da8c42800e3a40d08d33e33696c21230
Patient experiences with tissue‐based genomic testing during active surveillance for prostate cancer
Autor:
Michael S. Leapman, Ryan Sutherland, Cary P. Gross, Xiaomei Ma, Tyler M. Seibert, Matthew R. Cooperberg, William J. Catalona, Stacy Loeb, Dena Schulman‐Green
Publikováno v:
BJUI Compass, Vol 5, Iss 1, Pp 142-149 (2024)
Abstract Background Tissue‐based gene expression (genomic) tests provide estimates of prostate cancer aggressiveness and are increasingly used for patients considering or engaged in active surveillance. However, little is known about patient experi
Externí odkaz:
https://doaj.org/article/a14dc37891e3489084198101c440dd61
Autor:
Alice Guan, Eduardo J. Santiago-Rodríguez, Benjamin I. Chung, Janet K. Shim, Laura Allen, Mei-Chin Kuo, Kathie Lau, Zinnia Loya, James D. Brooks, Iona Cheng, Mindy C. DeRouen, Dominick L. Frosch, Todd Golden, John T. Leppert, Daphne Y. Lichtensztajn, Qian Lu, Debora Oh, Weiva Sieh, Michelle Wadhwa, Matthew R. Cooperberg, Peter R. Carroll, Scarlett L. Gomez, Salma Shariff-Marco
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Patients diagnosed with low-risk prostate cancer (PCa) are confronted with a difficult decision regarding whether to undergo definitive treatment or to pursue an active surveillance protocol. This is potentially further complicate
Externí odkaz:
https://doaj.org/article/aabab07a25854885916d582e6006fec5
Autor:
Neumair, Matthias, Kattan, Michael W., Freedland, Stephen J., Haese, Alexander, Guerrios-Rivera, Lourdes, De Hoedt, Amanda M., Liss, Michael A., Leach, Robin J., Boorjian, Stephen A., Cooperberg, Matthew R., Poyet, Cedric, Saba, Karim, Herkommer, Kathleen, Meissner, Valentin H., Vickers, Andrew J., Ankerst, Donna P.
Objective: We compared six commonly used logistic regression methods for accommodating missing risk factor data from multiple heterogeneous cohorts, in which some cohorts do not collect some risk factors at all, and developed an online risk predictio
Externí odkaz:
http://arxiv.org/abs/2109.10141
Autor:
Jang Hee Han, Annika Herlemann, Samuel L. Washington III, Peter E. Lonergan, Peter R. Carroll, Matthew R. Cooperberg, Chang Wook Jeong
Publikováno v:
The World Journal of Men's Health, Vol 41, Iss 4, Pp 940-950 (2023)
Purpose: Contemporary treatment strategies for localized prostate cancer (PCa) have been evolved over time. However, there is little data regarding survival outcomes based on initial treatment by risk group in this new era. This study aims to evalua
Externí odkaz:
https://doaj.org/article/338559f3a304419f9f29f2f3af3dad7b
Autor:
Samuel L. Washington III, Peter E. Lonergan, Janet E. Cowan, Shoujun Zhao, Jeanette M. Broering, Nynikka R. Palmer, Cameron Hicks, Matthew R. Cooperberg, Peter R. Carroll
Publikováno v:
Cancer Medicine, Vol 12, Iss 18, Pp 19234-19244 (2023)
Abstract Introduction We aim to characterize the magnitude of the work burden (weeks off from work) associated with prostate cancer (PCa) treatment over a 10‐year period after PCa diagnosis and identify those at greatest risk. Materials and Methods
Externí odkaz:
https://doaj.org/article/56ad4364eed64abcb3d7370d8bc0a82f
Autor:
Jang Hee Han, Sungyup Lee, Byounghwa Lee, Ock-kee Baek, Samuel L. Washington, Annika Herlemann, Peter E. Lonergan, Peter R. Carroll, Chang Wook Jeong, Matthew R. Cooperberg
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Although there are several decision aids for the treatment of localized prostate cancer (PCa), there are limitations in the consistency and certainty of the information provided. We aimed to better understand the treatment decision process a
Externí odkaz:
https://doaj.org/article/4578e0b672504e5ea491806cad64b0a3
Autor:
Giuseppe Fallara, Daniele Robesti, Daniele Raggi, Francesco Montorsi, Andrea Necchi, Matthew R. Cooperberg, Bernard Malavaud, Guillaume Ploussard, Alberto Martini
Publikováno v:
European Urology Open Science, Vol 52, Iss , Pp 40-43 (2023)
The PROpel trial assessed the combination of olaparib + abiraterone acetate (AA) plus prednisone and androgen deprivation therapy (ADT) versus AA plus prednisone and ADT alone as first-line treatment for metastatic castration-resistant prostate cance
Externí odkaz:
https://doaj.org/article/39ada7f2ca74494fb33cd14f94ba6048